1. a-L-Iduronidase activity was assayed by incubation of iduronosyl anhydro[ l-3H]mannitol 6-sulphate with homogenates of cultured skin fibroblasts, amniotic cells and leucocytes derived from normal individuals, patients affected with GLiduronidase deficiency disorder (mucopolysaccharidosis type I: Hurler, Scheie and Hurler-Scheie compound) and parents of such patients.
Introduction
ax-Iduronidase is a lysosomal enzyme involved in the degradation of iduronic acid-containing glycosaminoglycans, heparan sulphate and dermatan sulphate. Genetically determined deficiencies of this enzyme result in the well-known Hurler syndrome (mucopolysaccharidosis IH; MPS IH), the Scheie syndrome (MPS IS), a clinically mild variant, the Hurler-Scheie compound (MPS IH/S), of intermediate severity, and other more or less distinct phenotypes that do not fit into any of the previous three clinical groups (Leisti, Rimoin, Kaback, Hollister, den Tandt, Neufeld, Matalon & Philippart, 1975; Stevenson, Howell, McKusick, Suskind, Hanson, Elliot & Neufeld, 1976; Danes, 1977; McKusick, Neufeld & Kelly, 1978) . It is particularly important that all of these disorders that result from a deficiency of the same lysosomal enzyme, a-L-iduronidase, be differentiated from other mucopolysaccharidoses that. are phenotypically similar but genetically distinct.
In the past the most commonly used substrate for the assay of clc-L-iduronidase in vitro had been the synthetic phenyl a-L-iduronide. The assay procedure using cultured skin fibroblasts, amniotic cells and leucocytes is generally considered to be diagnostic for disorders resulting from a deficiency of this enzyme (Hall & Neufeld, 1973; Singh, Niebes & Di Ferrante, 1974; Dulaney, Milunsky & Moser, 1976) .
In view of the described variants of other lysosoma1 enzyme deficiencies, in which enzyme activity against artificial substrate may result in diagnostic anomalies when compared with the activity obtained with presumed natural substrates, it is important to use substrates wherever practicable that match as closely as possible the structure of the substrate in viuo (Tallman, Brady, Navon & Padeh, 1974; Owada, Sakiyama & Kitagawa, 1977; O'Brien, Norden, Miller, Frost & Kelly, 1977) .
Radiolabelled substrates iduronosyl anhydro[ 1-3H]mannitol (IM) and more recently iduronosyl anhydro[ l-3Hlmannitol 6-sulphate (IMs), which more closely match the structure of the presumed natural substrate heparan sulphate, have also been used to assay a-L-iduronidase activity (Di Natale, Leder & Neufeld, 1977; Hopwood & Muller, 1977; Hopwood, 1978) .
Here we report an evaluation of IMs as a substrate for the assay of a-L-iduronidase for the detection of heterozygotes and the post-and prenatal diagnosis of mucopolysaccharidosis I disorders. Hydrolysis of IMs by ac-L-iduronidase yields unlabelled iduronic acid and anhydro[ l-,HH]-mannitol 6-sulphate, as shown in Fig. 1 . The radioactive anhydromannitol sulphate is separated from IMs by high-voltage electrophoresis (Hopwood, 1978 ; J. J. Hopwood and V. Muller, unpublished observations).
Materials and methods

Cells
Peripheral blood leucocytes were prepared from 10 ml of heparinized whole blood by sedimentation in aqueous dextran (30 g/l); the final wash was with NaCl solution (0.15 mol/l) (Kampine, Brady, Kanfer, Feld & Shapiro, 1967) . Skin fibroblasts were cultured and harvested as previously described (Carey & Pollard, 1977) . Leucocytes and skin fibroblasts were suspended in aqueous Triton X-100 (1 g/l) and disrupted by freeze-thawing six times in solid CO$ethanol.
Each amniotic fluid sample (5-20 ml) was obtained by percutaneous needle amniocentesis at weeks 15-18 of gestation. Amniotic fluid cells were cultured on glass coverslips (6 mm x 22 mm) in 55 mm plastic Petri dishes by the techniques described by Sutherland, Grace & Bain (1973) and . Cells were harvested for enzyme assay by removing individual coverslips and washing the cells free of culture medium by immersion in three successive baths of NaCl solution (0.15 mol/l). Each coverslip was then centrifuged to remove excess NaCl solution, which has been shown to inhibit the cm-iduronidase activity assay towards IMs (Hopwood & Muller, 1977 ; J. J. Hopwood & V. Muller, unpublished observations) . The individual coverslips were then treated with 40 pl of aqueous Triton X-100 solution (1 g/l) in clear polystyrene conical-bottomed tubes (75 mm x 9 mm bore) with a 8 mm x 25 mm flat surface pressed into their sides. Coverslips were placed on the flat stage in contact with the Triton X-100 solution for a further 10 min. Each tube was then centrifuged at 500 g for 2 min, after which the coverslip was removed and inspected for the presence of cells. Most cells were removed from the coverslip by this procedure and could then be lysed by the freezethawing procedure described above. This method of cell preparation enabled small portions of cells, for the assay of several lysosomal enzyme activities, to be removed without disturbing the primary cell culture. Fibroblasts harvested with trypsin (Carey & Pollard, 1977) and freezethawed in Triton X-100 solution were shown to have a-L-iduronidase activities similar to those of fibroblasts harvested in Triton X-100 solution. Unless otherwise indicated the whole cell homogenates were immediately used in all enzyme assays.
Enzyme assays
IMs, specific radioactivity 493 pCi/pmol of uronic acid, prepared from heparin, was chemically and enzymically identified as previously described (Hopwood, 1978) . a-L-Iduronidase was assayed with IMs as substrate in incubation mixtures consisting of approximately 10 pg of leucocyte homogenate protein, 4 pg of fibroblast homogenate protein or 7 pg of amniotic fluid cell protein in sodium formate buffer (50 mmol/l), pH 3.6, and containing 460 pmol of IMs in a final volume of 12 pl. Incubation was at 37OC for 1 h, 2 h and 4 h for mixtures containing fibroblasts, leucocytes and amniotic cell homogenates respectively. Incubations with fibroblasts from mucopolysaccharidosis I patients contained approximately 20 pg of homogenate protein and were incubated for 2 h at 37OC. It has been shown that these conditions were optimum for IMs degradation by ac-L-iduronidase (J. J. Hopwood .& V. Muller, unpublished observations). After incubation, the whole reaction mixture was subjected to highvoltage electrophoresis at pH 1.7 as described below.
Sulphoiduronate sulphatase activity was determined by the method of Lm, Leder, Bach & Neufeld (1974) , with modifications previously described (Hopwood, 1978) . /3-GlucuronidaseY / 3-galactosidase and total hexosaminidase were determined as previously described (Carey & Pollard, 1977) . Sulphamidase activity was assayed by the method described by Whiteman & Young (1977) .
General methods
High-voltage electrophoresis was performed on Whatman 3MM chromatography paper in formic acid (1 -74 mol/l), pH 1 -7, at 45 V/cm for 1 h with a €AMAG HVE system (CAMAG ChemieErzengnisse und Adsorptionstechnik AG, Switzerland) or at 42 V/cm for 50 min with a Shandon Southern (model L24) HVE system (Shandon Southern Products Ltd, Runcorn, Cheshire, U.K. Protein was determined by the Folin method of Lowry, Rosebrough, Farr & Randall (1951) . Enzyme activities were expressed as pmol min-' mg-l of protein. Accumulation of [35Slmucopoly-saccharide in cultured skin fibroblasts and amniotic fluid cells was measured by using the method described by Cantz, Kresse, Barton & Neufeld (1972) .
Results and discussion
Postnatal assessment of a-L-iduronidase activity
The activity of a-L-iduronidase, measured with IMs as substrate in a group of individuals at risk for a-L-iduronidase deficiency, is shown in Table 1 and Fig Table 2 and Fig. 3 . Only in one couple (W.) do the a-L-iduronidase activities for both leucocyte and skin fibroblast preparations fall below the lowest value in each cell type normal range. Both parents in the B. family are clearly within the normal fibroblast enzyme range, whereas only one member in the other families is below the lowest normal range value. Another couple (P., Table 2 ), for which blood was not available, have fibroblast a-L-iduronidase activities below the lowest normal value. Thus it appears from these results that there is overlap between the obligate heterozygote and normal range of cc-L-iduronidase activities for both leucocyte and skin fibroblast preparations.
The B. family is the only family in this series with two adduronidase-deficient children and therefore are perhaps the only definite obligate heterozygotes in the series. Both B. parents have leucocyte a-L-iduronidase activities, which are consistent with heterozygote status: however, both have fibroblast enzyme activities within the normal range.
The activities in normal leucocyte and skin fibroblast preparations show considerable individual variability, but are in good agreement with assays performed at different times on the same sample (or with a different sample on the same individual). Nevertheless, they reveal a significant difference with leucocytes and cultured skin fibroblasts from Hurler or Scheie patients. Thus the technique using a radiolabelled natural substrate represents a satisfactory procedure for the assessment of GLiduronidase deficiencies.
Assuming that the GL-iduronidase activity is proportional to gene dose and variation of enzyme activity is not due to extraneous non-genetic factors, there are several explanations for obligate heterozygote enzyme activities falling within the normal range. We have recently shown that lymphocytes have approximately a twofold greater GL-iduronidase activity than granulocytes (J. J.
Hopwood & , V. Muller, unpublished observations).
However, this present study assayed a-L-iduronidase activities in mixed leucocyte homogenates without consideration of the relative number of lymphocytes in the leucocyte preparation. Some of the enzyme quantitative variation may arise from multiple allelism or from variation in genes at other loci that may affect the overall a-L-iduronidase activity. It is also possible that individuals, particularly where both leucocyte and skin fibroblast ax-iduronidase activity for the obligate heterozygote fall within the normal range (for example, S. male parent, Table 2 ), are not heterozygous for this enzyme deficiency. In this case the homozygous affected child may result from a sporadic mutation at the a-L-iduronidase locus of the normal parent in combination with a true heterozygote in the other parent.
Finally it should be emphasized that the activities of cultured fibroblast lysosomal enzymes vary with culture conditions (Ryan, Lee & Nadler, 1972; Carey & Pollard, 1977) . The significance of this latter source of variation may be reduced by the concomitant assay of other lysosomal enzymes and the expression of activity as a ratio (Hall & Neufeld, 1973) . However, the lysosomal enzyme activity values recorded in Table 3 for the S. family leucocytes and skin fibroblasts show that the ratio of a-L-iduronidase to /3-glucuronidase or /3-N-acetylglucosaminidase (data not shown) does not shift the a-L-iduronidase activity of S. male 
Prenatal assessment of a-L-iduronidase activity
The absence of previous biochemical diagnoses on index cases is a serious problem that is widely encountered in prenatal assessment for the mucopolysaccharidoses. In our experience, some cases, diagnosed on clinical evidence as a particular mucopolysaccharidosis type, have subsequently been shown by enzyme-activity measurements and sulphate-uptake studies to be either a different mucopolysaccharidosis type or not belonging to a known polysaccharide storage type. It is therefore most important that index cases diagnosed clinically be confirmed by enzyme-activity measurements, otherwise incorrect antenatal diagnostic tests may be performed.
Enzyme data from five prenatal assessments for deficiency of GL-iduronidase activity measured with IMs as substrate are recorded in Table 4 . In cases 1 to 3, cultured skin fibroblasts from the propositus were available and demonstrated GLiduronidase activities diagnostic of mucopolysaccharidosis I. As the propositi in cases 4 and 5 were diagnosed on clinical evidence only, heterozygote studies were attempted on leucocytes and cultured skin fibroblasts isolated from each parent. In case 4 (R. family) the a-L-iduronidase activities in leucocyte and skin fibroblast homogenates from both parents were within the heterozygote range ( Table 2) . Leucocytes isolated from the parents (G. family) in case 5 gave cc-L-iduronidase values that were middle of normal range (Tables 1 and 2), whereas their cultured skin fibroblast preparations gave GL-iduronidase activity values consistent with heterozygous status (Tables 1 and 2) . Because the propositi in cases 4 and 5 were not positively identified by enzyme assay, amniotic cells in these cases were also assessed for [35Slmucopoly-saccharide accumulation, sulphoiduronate sulphatase, sulpharnidase and P-glucuronidase activities. As was observed with GL-iduronidase ( Table 4) , all of these enzyme activities and [35S]-mucopolysaccharide accumulation were within normal control values.
The GL-iduronidase activity in the foetal amniotic fluid cells from case 1 was threefold lower than the lowest normal control and approximately twofold higher than the a-L-iduronidase value obtained for cultured skin fibroblasts isolated from Michaelis-Menten constants were calculated by linear regression analysis of Lineweaver-Burk plots (Fig. 4) . the propositus. It was difficult to decide whether the amniotic fluid cell a-L-iduronidase activity in case 1 was a result of homozygous expression of the disorder, as shown by the cultured skin fibroblasts from the propositus, or due to a low heterozygote value as expressed by leucocyte preparations isolated from the mother. The diagnostic dilemma was resolved by comparing the Lineweaver-Burk plots (Fig. 4) of a-L-iduronidase hydrolysis of IMs by fibroblasts derived from the propositus, a normal control and amniotic fluid cells from the foetus at risk and normal controls. Despite the large errors involved in such treatment of enzyme kinetic data, the apparent K, values for the cells derived from the foetus at risk, heterozygotes and normal controls are similar and are at least 20-fold lower than K, values obtained for the cultured skin fibroblast preparation from the propositus ( Table  5) . Hence it is probable that the foetus at risk in case 1 is heterozygous and not homozygous for ct-L-iduronidase deficiency, a conclusion which appears to be confirmed by the corresponding postnatal follow-up data obtained from leucocyte were consistent with the normal or heterozygote assessment of risk.
The radiolabelled substrate IMs has been used to assay a-L-iduronidase activity in cultured skin fibroblasts, amniotic cells and leucocyte homogenates. This method has been shown to be suitable and sensitive for the post-and pre-natal diagnosis of the type I mucopolysaccharidoses.
